201 related articles for article (PubMed ID: 24785761)
1. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.
van de Giessen E; Celik F; Schweitzer DH; van den Brink W; Booij J
J Psychopharmacol; 2014 Sep; 28(9):866-73. PubMed ID: 24785761
[TBL] [Abstract][Full Text] [Related]
2. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia.
Gevonden M; Booij J; van den Brink W; Heijtel D; van Os J; Selten JP
JAMA Psychiatry; 2014 Dec; 71(12):1364-72. PubMed ID: 25271822
[TBL] [Abstract][Full Text] [Related]
3. The correlation between striatal dopamine D2/D3 receptor availability and verbal intelligence quotient in healthy volunteers.
Guo JF; Kuang Yang Y; Tsing Chiu N; Lieh Yeh T; See Chen P; Lee IH; Lin Chu C
Psychol Med; 2006 Apr; 36(4):547-54. PubMed ID: 16359604
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss.
van der Zwaal EM; de Weijer BA; van de Giessen EM; Janssen I; Berends FJ; van de Laar A; Ackermans MT; Fliers E; la Fleur SE; Booij J; Serlie MJ
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1190-200. PubMed ID: 27184782
[TBL] [Abstract][Full Text] [Related]
5. Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats.
van de Giessen E; de Bruin K; la Fleur SE; van den Brink W; Booij J
Eur Neuropsychopharmacol; 2012 Apr; 22(4):290-9. PubMed ID: 21889317
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine D2/D3 receptor availability in male smokers.
Yang YK; Yao WJ; McEvoy JP; Chu CL; Lee IH; Chen PS; Yeh TL; Chiu NT
Psychiatry Res; 2006 Jan; 146(1):87-90. PubMed ID: 16343861
[TBL] [Abstract][Full Text] [Related]
7. Association of novelty seeking scores and striatal dopamine D₂/D₃ receptor availability of healthy volunteers: single photon emission computed tomography with ¹²³i-iodobenzamide.
Huang HY; Lee IH; Chen KC; Yeh TL; Chen PS; Yang YK; Chiu NT; Yao WJ; Chen CC
J Formos Med Assoc; 2010 Oct; 109(10):736-9. PubMed ID: 20970071
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
[TBL] [Abstract][Full Text] [Related]
9. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
Abi-Dargham A; Kegeles LS; Zea-Ponce Y; Mawlawi O; Martinez D; Mitropoulou V; O'Flynn K; Koenigsberg HW; Van Heertum R; Cooper T; Laruelle M; Siever LJ
Biol Psychiatry; 2004 May; 55(10):1001-6. PubMed ID: 15121484
[TBL] [Abstract][Full Text] [Related]
10. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity.
van de Giessen E; la Fleur SE; Eggels L; de Bruin K; van den Brink W; Booij J
Int J Obes (Lond); 2013 May; 37(5):754-7. PubMed ID: 22868829
[TBL] [Abstract][Full Text] [Related]
11. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
[TBL] [Abstract][Full Text] [Related]
12. Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder.
Vulink NC; Planting RS; Figee M; Booij J; Denys D
Eur Neuropsychopharmacol; 2016 Feb; 26(2):350-356. PubMed ID: 26711686
[TBL] [Abstract][Full Text] [Related]
13. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
[TBL] [Abstract][Full Text] [Related]
14. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
Abi-Dargham A; Gil R; Krystal J; Baldwin RM; Seibyl JP; Bowers M; van Dyck CH; Charney DS; Innis RB; Laruelle M
Am J Psychiatry; 1998 Jun; 155(6):761-7. PubMed ID: 9619147
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls.
Schrantee A; Ferguson B; Stoffers D; Booij J; Rombouts S; Reneman L
Brain Imaging Behav; 2016 Jun; 10(2):548-58. PubMed ID: 26149196
[TBL] [Abstract][Full Text] [Related]
16. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.
Heinz A; Siessmeier T; Wrase J; Buchholz HG; Gründer G; Kumakura Y; Cumming P; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
Am J Psychiatry; 2005 Aug; 162(8):1515-20. PubMed ID: 16055774
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
Schneier FR; Abi-Dargham A; Martinez D; Slifstein M; Hwang DR; Liebowitz MR; Laruelle M
Depress Anxiety; 2009; 26(5):411-8. PubMed ID: 19180583
[TBL] [Abstract][Full Text] [Related]
18. Brain dopamine and obesity.
Wang GJ; Volkow ND; Logan J; Pappas NR; Wong CT; Zhu W; Netusil N; Fowler JS
Lancet; 2001 Feb; 357(9253):354-7. PubMed ID: 11210998
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine D2/3 receptor availability in treatment resistant depression.
de Kwaasteniet BP; Pinto C; Ruhé HG; van Wingen GA; Booij J; Denys D
PLoS One; 2014; 9(11):e113612. PubMed ID: 25411966
[TBL] [Abstract][Full Text] [Related]
20. SPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle M; Abi-Dargham A; van Dyck CH; Rosenblatt W; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Charney DS; Hoffer PB; Kung HF
J Nucl Med; 1995 Jul; 36(7):1182-90. PubMed ID: 7790942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
